Envestnet Asset Management Inc Trinity Biotech PLC Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.87 - $1.18 $41,201 - $55,882	-47,358 Reduced 47.14%	53,099 $49,000
Q3 2022 Nov 10, 2022	BUY	$1.09 - $5.45 $2,605 - $13,025	2,390 Added 2.44%	100,457 $108,000
Q1 2022 May 04, 2022	SELL	$0.92 - $1.44 $11,807 - $18,480	-12,834 Reduced 11.57%	98,067 $104,000
Q4 2021 Feb 04, 2022	BUY	$1.43 - $2.25 $158,588 - $249,527	110,901 New	110,901 $159,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $42.7M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.